Acetylsalicylic Acid EP Impurity A-13C6

Aspirin-A National Survey V: Determination of Aspirin and Impurities in Enteric Coated Tablets and Suppository Formulations and In Vitro Dissolution of Enteric Coated Tablets
Ross D. Kirchhoefer , Everett jefferson, and Paul e. flinn
Journal of Pharmaceutical Sciences I 1049 Vol. 71, No. 9. September 7982
 
Solubility of Benzoic Acid and Aspirin in Pure Solvents Using Focused Beam Reflective Measurement
Gavin Tully,† Guangyang Hou,† and Brian Glennon
J. Chem. Eng. Data 2016, 61, 1, 594–601
 
Isolation, Characterization of a Potential Degradation Product of Aspirin and an HPLC Method for Quantitative Estimation of Its Impurities
Subasranjan Acharya, Alex Daniel, Bharath Gyadangi, Sriramulu Ramsamy
Journal of Chromatographic Science, Volume 53, Issue 9, October 2015, Pages 1491–1497
 
Extensive Study of Aspirin and Its Related Impurities Under Various Stressed Conditions in Low Dose Aspirin and Esomeprazole Magnesium Capsules
Palavai Sripal Reddy1,2, Shakil Sait1, Kishore Kumar Hotha
Am. J. PharmTech Res. 2012; 2(6)
 
Determination of trace element impurities in aspirin tablets by neutron activation analysis
F. y. iskander, d. e. klein, t. l. bauer
Journal of Radio analytical and Nuclear Chemistry, Articles, 9 7/2 (1986) 353 35 7

Acetylsalicylic Acid EP Impurity A-13C6 is chemically 4-Hydroxybenzoic-1,2,3,4,5,6-13C6 acid. Acetylsalicylic Acid EP Impurity A-13C6 is supplied with detailed characterization data compliant with regulatory guideline. Acetylsalicylic Acid EP Impurity A-13C6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Aspirin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.